DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 44 microgram/mL recall — FDA D-0337-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
Monthly breakdown
2023 recalls by month
Select a month to review the recall records reported during that period.
December 2023295 records · 4 categoriesNovember 2023387 records · 4 categoriesOctober 2023214 records · 4 categoriesSeptember 2023253 records · 4 categoriesAugust 2023478 records · 4 categoriesJuly 2023263 records · 4 categoriesJune 2023339 records · 4 categoriesMay 2023410 records · 4 categoriesApril 2023189 records · 4 categoriesMarch 2023788 records · 4 categoriesFebruary 2023253 records · 4 categoriesJanuary 2023205 records · 4 categories
2023 recalls — page 151
Records are ordered by the best available source date.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 13 microgram/mL recall — FDA D-0331-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 100 microgram/mL recall — FDA D-0332-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 88 microgram/mL recall — FDA D-0341-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 125 microgram/mL recall — FDA D-0333-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 37.5 microgram/mL recall — FDA D-0336-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 112 microgram/mL recall — FDA D-0342-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL recall — FDA D-0334-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
Tacrolimus Capsules, USP, 0.5 mg, 100-count bottle recall — FDA D-0330-2023
Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules.
Class IIFDA: OngoingDr. Reddy's Laboratories, Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 62.5 microgram/mL recall — FDA D-0339-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL recall — FDA D-0344-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 75 microgram/mL recall — FDA D-0340-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
SODIUM CHLORIDE 0.9% Sodium Chloride Injection, USP, 1000 mL Excel Plus Container recall — FDA D-0346-2023
Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL Plus IV Container product due to the possibility of an incomplete seal that may…
Class IIFDA: CompletedB. Braun Medical Inc.
DrugMar 1, 2023
SODIUM CHLORIDE 0.9% Sodium Chloride Injection, USP, 500 mL Excel Plus Container recall — FDA D-0347-2023
Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL Plus IV Container product due to the possibility of an incomplete seal that may…
Class IIFDA: CompletedB. Braun Medical Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 137 microgram/mL recall — FDA D-0343-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 200 microgram/mL recall — FDA D-0345-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
VehicleFeb 27, 2023
Model Y critical fasteners recall — NHTSA campaign 23V130000
Tesla, Inc. (Tesla) is recalling certain 2022-2023 Model Y vehicles. The bolts securing the second-row seat back frames may not have been securely tightened.
critical fastenersTesla, Inc.
VehicleFeb 24, 2023
Ford axle recall — NHTSA campaign 23V128000
Ford Motor Company (Ford) is recalling certain 2023 F-150, Expedition, and Lincoln Navigator vehicles. The front axle pinion may not have been heat-treated, which can cause it to fracture.
axleFord Motor Company
VehicleFeb 23, 2023
Chrysler clutch recall — NHTSA campaign 23V116000
Chrysler (FCA US, LLC) is recalling certain 2018-2023 Jeep Wrangler, and 2020-2023 Jeep Gladiator vehicles equipped with manual transmissions. The clutch pressure plate may overheat and…
clutchChrysler (FCA US, LLC)
Medical DeviceFeb 22, 2023
MEDLINE INDUSTRIES, LP - Northfield Surgical convenience kits labeled as: a) MEDLINE PERF recall — FDA Z-1120-2023
The recall is due to the perforated bag not allowing for outside of the kit wrapping to be sterile, therefore, only the contents inside the kits wrapping are sterile.
Class IIFDA: OngoingMEDLINE INDUSTRIES, LP - Northfield
Medical DeviceFeb 22, 2023
MicroPort Orthopedics EVOLUTION MP Tibial Bases, Size 2+ LEFT, REF ETPKN2PL, knee tibial recall — FDA Z-0275-2023
One confirmed incident has been received that ETPKN2PL lot 1916559, size 2 Evolution MP Tibial Base, was opened during surgery and contained ETPKN7SL lot 1916715, size 7 Evolution MP Tibial…
Class IIFDA: OngoingMicroPort Orthopedics Inc.
Medical DeviceFeb 22, 2023
OrthoPediatrics Orthex Large Bone Shoulder Bolt, model no recall — FDA Z-0277-2023
Bolt breakage on the head or threaded portion, which may cause loss of strut continuity with frame. This may cause loss of deformity correction and/or disruption of bone regeneration.
Class IIFDA: OngoingOrthoPediatrics Corp
Medical DeviceFeb 22, 2023
MEDLINE INDUSTRIES, LP - Northfield Surgical convenience kits labeled as: MEDLINE SHOULDER recall — FDA Z-1122-2023
The recall is due to the perforated bag not allowing for outside of the kit wrapping to be sterile, therefore, only the contents inside the kits wrapping are sterile.
Class IIFDA: OngoingMEDLINE INDUSTRIES, LP - Northfield
Medical DeviceFeb 22, 2023
MEDLINE INDUSTRIES, LP - Northfield Surgical convenience kits labeled as: a) MEDLINE HAND recall — FDA Z-1128-2023
The recall is due to the perforated bag not allowing for outside of the kit wrapping to be sterile, therefore, only the contents inside the kits wrapping are sterile.
Class IIFDA: OngoingMEDLINE INDUSTRIES, LP - Northfield
About the 2023 recall archive
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.